Old Web
English
Sign In
Acemap
>
authorDetail
>
Donald Alan Bergstrom
Donald Alan Bergstrom
Medicine
in patient
first in human
Small molecule
Pharmacodynamics
2
Papers
4
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (2)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
A phase Ib, first-in-human, dose escalation and expansion study of XMT-1522, a novel antibody-drug conjugate (ADC) directed against HER2, in patients with advanced breast cancer and other advanced tumors expressing HER2.
2017
Journal of Clinical Oncology
Howard A. Burris
Minal Barve
Erika Paige Hamilton
Aditya Bardia
Hatem Soliman
Donna Jarlenski
Rebecca Mosher
Donald Alan Bergstrom
Show All
Source
Cite
Save
Citations (3)
A phase 1 first-in-human study of XMT-1107, a polymer-conjugated fumagillol derivative, in patients (pts) with advanced solid tumors.
2014
Journal of Clinical Oncology
Johanna C. Bendell
Geoffrey I. Shapiro
Edward A. Sausville
Suzanne F. Jones
John Frederick Hilton
Dana Shkolny
Burkhard Blank
Donald Alan Bergstrom
Show All
Source
Cite
Save
Citations (1)
1